ACCURAY INCORPORATED
Moat Score — Accuray Incorporated
Total Moat Score
12 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 3 / 5 | Accuray holds patents and decades of clinical evidence supporting its differentiated CyberKnife robotic radiosurgery and TomoTherapy helical IMRT platforms, real technical and clinical-data moats even though it is smaller than industry leaders Varian and Elekta. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 1 / 5 | As a smaller radiation therapy equipment maker, Accuray lacks the manufacturing scale and R&D budget of Varian (Siemens Healthineers) and Elekta, giving it no structural cost advantage. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 2 / 5 | Differentiated clinical capabilities support reasonable capital equipment and service contract pricing, but large hospital system purchasing power and competition from bigger, broader-portfolio rivals constrain outright pricing power. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | Radiation therapy equipment exhibits no network effect - a system's clinical value to one hospital is unrelated to how many other hospitals use similar equipment. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 4 / 5 | Radiation therapy systems represent major, multi-year hospital capital investments with extensive staff training, treatment planning integration, and clinical workflow dependency, making switching to a competing platform costly and disruptive once installed. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 2 / 5 | The specialized robotic radiosurgery and helical IMRT niches Accuray focuses on are narrow enough that they may not support unlimited competing platforms, giving Accuray some efficient-scale protection within its specific technology categories. |